Healthcare - Biotechnology - NASDAQ - US
$ 9.905
-11.1 %
$ 618 M
Market Cap
-1.31
P/E
BALANCE SHEET
149 M
ASSETS
28.7 M
LIABILITIES
120 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Immunome, Inc.
| Current Assets | 145 M |
| Cash & Short-Term Investments | 138 M |
| Receivables | 289 K |
| Other Current Assets | 6.27 M |
| Non-Current Assets | 3.84 M |
| Long-Term Investments | 100 K |
| PP&E | 3.64 M |
| Other Non-Current Assets | 100 K |
| Current Liabilities | 21.8 M |
| Accounts Payable | 3.31 M |
| Short-Term Debt | 310 K |
| Other Current Liabilities | 18.2 M |
| Non-Current Liabilities | 6.83 M |
| Long-Term Debt | 1.34 M |
| Other Non-Current Liabilities | 5.49 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 98.7 | 20.3 | 49.2 | 39.8 | 2.5 | 1.6 |
| Short Term Investments | 39.5 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0.3 | 0.8 | 4.3 | 0.8 | 0 | 0 |
| Inventory | 0 | (0.8) | (4.3) | (0.9) | 0 | 0 |
| Other Current Assets | 6.3 | 2.9 | 2.6 | 5.4 | 0.6 | 1.0 |
| Total Current Assets | 144.7 | 22.6 | 56.6 | 42.9 | 3.1 | 2.1 |
| PP&E | 3.6 | 1.0 | 0.9 | 1.5 | 1.7 | 2.1 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 100 K | 100 K | 100 K | 100 K | 100 K | 100 K |
| Other Long Term Assets | 100 K | 0.3 | 0.3 | 0 | 0.1 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 148.5 | 24.0 | 57.9 | 44.5 | 5.1 | 4.4 |
| LIABILITIES | ||||||
| Accounts Payable | 3.3 | 2.4 | 3.1 | 1.2 | 0.5 | 0.5 |
| Short Term Debt | 0.3 | 0.2 | 0.3 | 0.5 | 0.5 | 0.6 |
| Other Current Liabilities | 7.7 | 4.7 | 6.3 | 1.4 | 0.7 | 0.5 |
| Total Current Liabilities | 21.8 | 7.3 | 9.7 | 3.0 | 1.7 | 1.6 |
| Long Term Debt | 1.3 | 62 K | 0 | 0.1 | 0.1 | 0.6 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 12 K | 8 K | 38.9 | 27.5 |
| Total Liabilities | 28.7 | 7.4 | 9.7 | 3.2 | 40.7 | 29.7 |
| EQUITY | ||||||
| Common Stock | 4 K | 1 K | 1 K | 1 K | 1 K | 1 K |
| Retained Earnings | (222.8) | (116.0) | (79.1) | (54.4) | (36.6) | (26.1) |
| Other Accumulative Comprehensive Income/Loss | 22 K | 0 | (57.9) | (44.5) | (38.9) | (0.9) |
| Total Equity | 119.9 | 16.7 | 48.2 | 41.3 | (35.6) | (25.2) |
| Total Liabilities and Equity | 148.5 | 24.0 | 57.9 | 44.5 | 5.1 | 4.4 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 19.8 | 12.1 | 11.5 | 3.4 | 5.7 | 4.4 |